16 completed, 8 unknown, 2 terminated, 1 not yet recruiting. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 16, Unknown 8, Terminated 2, Not yet recruiting 1 |
Follow cetrorelix: new trials by email Literature Review of cetrorelix trials Research Report on cetrorelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles. Control Group (A):, Test Group (B): - Assisted Reproductive Techniques | Phase 4 | Not yet recruiting | Trust Fertility Clinic | 230 | 2026-01-01 | 2026-01-20 |
| GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst Cetrorelix Acetate, Ganerelix Acetate - IVF, Ovarian Cysts | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-05-01 | 2021-10-13 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection Cetrorelix, Leuprolide Acetate - Polycystic Ovary Syndrome | Phase 4 | Unknown | Assiut University | 150 | 2019-12-07 | 2020-03-25 |
| Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | ClinAmygate | 300 | 2019-07-01 | 2019-11-21 |
| Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders Growth Hormones Somatropin Recombinant, Placebo saline solution - Infertility, Female | Phase 4 | Completed | ClinAmygate | 156 | 2018-12-20 | 2019-06-24 |
| Frozen Embryo Transfer With GnRH-antagonist Trial Cetrorelix Acetate - Infertility | Phase 4 | Unknown | University of Oxford | 300 | 2018-12-13 | 2019-04-25 |
| Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction Estradiol patch, Cetrotide, Fasting - Heart Diseases, Left Ventricular Dysfunction | Phase 4 | Unknown | The University of Texas at Arlington | 100 | 2018-09-13 | 2024-02-20 |
| Cetrorelix and Ganirelix Flexible Protocol for (IVF) Ganirelix Acetate, Cetrorelix Acetate - Infertility/Sterility | Phase 4 | Unknown | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | 100 | 2017-11-15 | 2018-03-27 |
| Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI Triptorelin, cetrorelix, Recombinant Follicle Stimulating Hormone - Invitro Fertilization | Phase 4 | Completed | Cairo University | 204 | 2017-04-21 | 2017-11-07 |
| NATural Ovarian Stimulation Gonal-F®, Cetrotide® - Infertility | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 129 | 2017-01-13 | 2026-04-03 |
| Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization | Phase 4 | Terminated | Andros Day Surgery Clinic | 60 | 2016-12-20 | 2020-01-10 |
| Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles combined oral contaraceptive pills, recombinant FSH, Urinaru gonadotropin - Assisted Reproduction | Phase 4 | Completed | Cairo University | 160 | 2016-07-20 | 2019-07-05 |
| The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization. GnrH Antagonist/letrozole protocol (Cetrotide; serono + Femara; Novartis Pharma AG), microdose flare-up protocol (Lucrin; Abbott + Gonal F, Serono), Antagonist/clomiphene protocol (Cetrotide; serono + Klomen, Kocak pharma) - Poor Responders Undergoing IVF | Phase 4 | Unknown | Pınar Özcan Cenksoy | 100 | 2014-01-01 | 2014-01-15 |
| Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF Clomiphene citrate, Daily FSH and LH plus Cetrorelix, Triptorelin plus daily FSH anh LH - Poor Responders, IVF | Phase 4 | Unknown | Bioroma | 250 | 2014-01-01 | 2014-07-28 |
| Assessment of Implantation Potential of Embryos by Time-lapse Technology recombinant Follicle Stimulating Hormone (rFSH) - Embryo/Fetus Death, Blastocyst Disintegration | Phase 4 | Unknown | Bloom IVF and Fertility Centre | 200 | 2012-12-01 | 2013-01-04 |
| Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) Menotrophin, Follitrophin alpha, Cetrorelix - Infertility | Phase 4 | Completed | Ferring Pharmaceuticals | 124 | 2010-10-01 | 2014-03-14 |
Showing 20 of 27. Sign in to see all of them.
Infertility (12) · Polycystic Ovary Syndrome (3) · Aneuploidy (1) · Embryo Loss (1) · Fasting (1) · Heart Diseases (1) · Infertility, Female (1) · Leiomyoma (1) · Ovarian Cysts (1) · Ovarian Hyperstimulation Syndrome (1) · Stillbirth (1) · Ventricular Dysfunction, Left (1)
Damascus University (4) · Cairo University (2) · ClinAmygate (2) · Andros Day Surgery Clinic (1) · Aristotle University Of Thessaloniki (1) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Bart CJM Fauser (1) · Bioroma (1) · Bloom IVF and Fertility Centre (1) · EMD Serono (1) · Ferring Pharmaceuticals (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Pınar Özcan Cenksoy (1)
Egypt (5) · Syria (4) · Italy (3) · United Kingdom (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Greece (1) · India (1) · Israel (1) · Netherlands (1) · Spain (1) · United States (1)
Abdul Hakim Nattouf, MD, PhD (4) · Marwan Alhalabi, MD, PhD (4) · Sally Kadoura, B Pharm, MD (4) · Adolfo Allegra, MD (1) · Ahmed Maged, MD (1) · Allison M Case, MD FRCSC (1) · Angela R Baerwald, PhD (1) · Eduardo Kelly, MD, MBA (1) · Efstratios Kolibianakis (1) · Eman Elgendy, MD (1) · Gian Mario Tiboni, professor (1) · Hrishikesh D Pai, M.D. (1)
PMID 17854523, PMID 18765009, PMID 20637457, PMID 22819187, PMID 23809501, PMID 24129613, PMID 24608161, PMID 24929258, PMID 33011968, PMID 33495008, PMID 34808697
2018 (1)